Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!
Top 5 New Entrants companies in Dengue vaccine by Most Patent Filing In 5 Years in the United States in 2018
The Dengue vaccine top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filing In 5 Years Dengue vaccine New Entrants in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Dengue vaccine is a vaccine to prevent dengue fever in humans. The World Health Organization (WHO) only recommends the vaccine in those who have previously had dengue fever or populations in which most people have been previously infected. The value of this vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected.